Pennsylvania Patent of the Month – June 2021
Postpartum depression is a form of depression that affects some women following giving birth to a child. Studies suggest that it is the result of rapidly declining postpartum progesterone and allopregnanolone levels. Women can also experience Premenstrual dysphoric disorder (PMDD) – which can lead to severe mood swings and depression. A third disorder -postmenopausal depression – is yet another major depressive disorder than can impact women. Allopregnanolone has been suggested as a treatment option for each of these depressive disorders, but it has quite a few limitations like short half-life and limited administration methods. Marinus Pharmaceuticals, Inc. has developed an alternative treatment option involving a neurosteroid formulation.
Ganaxolone is a synthetic steroid with anti-convulsant activity. It’s been used for treatment in epilepsy and other CNS disorders. It has a long half-life – nearly 20 hours in human plasma following oral administration. Allopregnanolone has a falh-life of 45 minutes in the same conditions. Marinus Pharmaceuticals has developed a neurosteroid solution that combines ganaxolone with stabilizers and surfactants. The initial treatment is injectable, followed by oral doses. This treatment option aims to meet the needs of these major depressive disorders with fewer limitations.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
